MTOR and renal cell carcinoma: Knockdown of FAP expression attenuates the activity of the PI3K/AKT/mTOR signaling pathway, thereby inhibiting the growth of RCC, suggesting that targeting FAP may be a potential therapeutic strategy for RCC treatment.44